Bristol-Myers Squibb Co at Citi Global Healthcare Conference Transcript
()-
Geoff Meacham, I'm a senior biopharma analyst, and we're thrilled today, to have Bristol-Myers with us on stage. We have, CFO David Elkins. We also have Adam Lenkowsky, Head of Commercial. So guys, welcome. Thanks for having us.
Questions & Answers
()-
Well, we have a number of questions to go over, partly, finance, partly commercial, but maybe, for you guys, let's just talk about yesterday's news with respect to the Cobenfy study. That's the probably the more topical thing to -- give us some context for kind of the trial amendments.
Happy to do that, Jeff. So as you're aware, yesterday we announced that the ADEPT-2 study would continue, and we would enroll additional patients into the study. If we take a step back, if you remember, on our Q2 earnings call, we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
